NSBCX
Price
$57.77
Change
+$0.70 (+1.23%)
Updated
Apr 23 closing price
Net Assets
5.7B
VSTSX
Price
$252.58
Change
+$4.17 (+1.68%)
Updated
Apr 23 closing price
Net Assets
1.7T
Ad is loading...

NSBCX vs VSTSX

Header iconNSBCX vs VSTSX Comparison
Open Charts NSBCX vs VSTSXBanner chart's image
Nuveen Dividend Growth C
Price$57.77
Change+$0.70 (+1.23%)
VolumeN/A
Net Assets5.7B
Vanguard Total Stock Mkt Idx Instl Sel
Price$252.58
Change+$4.17 (+1.68%)
VolumeN/A
Net Assets1.7T
NSBCX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NSBCX vs. VSTSX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSBCX is a Buy and VSTSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.7T vs. NSBCX (5.7B). VSTSX pays higher dividends than NSBCX: VSTSX (1.37) vs NSBCX (0.16). NSBCX was incepted earlier than VSTSX: NSBCX (19 years) vs VSTSX (9 years). NSBCX (1.67) is less costly to investors than VSTSX (0.01). NSBCX is a more actively managed with annual turnover of: 11.00 vs. VSTSX (2.00). NSBCX has a lower initial minimum investment than VSTSX: NSBCX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 3.54 vs. NSBCX (0.58). VSTSX return over 5 years is better than : 83.81 vs. NSBCX (48.92).
NSBCXVSTSXNSBCX / VSTSX
Total Expense Ratio1.670.0116,700%
Annual Report Gross Expense Ratio1.670.0116,700%
Fund Existence19 years9 years-
Gain YTD-6.996-10.51967%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.7B1.7T0%
Annual Yield % from dividends0.161.3712%
Returns for 1 year0.583.5416%
Returns for 3 years8.8621.4141%
Returns for 5 years48.9283.8158%
Returns for 10 years60.72N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEON9.870.54
+5.79%
Neonode
PMCB1.190.05
+3.93%
PharmaCyte Biotech
BANF118.782.08
+1.78%
BancFirst Corp
NWSA26.530.35
+1.34%
News Corp
CVAC3.17-0.02
-0.63%
CureVac NV